ClinicalTrials.Veeva

Menu

CPAP Device In-lab Assessment NZ

Fisher & Paykel Healthcare logo

Fisher & Paykel Healthcare

Status

Completed

Conditions

Obstructive Sleep Apnea

Treatments

Device: CPAP with no comfort feature
Device: CPAP with comfort feature B
Device: CPAP with comfort feature A
Device: Auto CPAP with comfort feature A+B
Device: CPAP with comfort feature A + B
Device: Auto CPAP with comfort feature B
Device: Auto CPAP + comfort feature A
Device: CPAP at Sub therapeutic level
Device: Auto CPAP with no comfort feature

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this trial is to assess device performance against participants in an overnight study to ensure the product meets user and clinical requirements

Full description

Existing Adult Continuous Positive Airway Pressure (CPAP) therapy users will be recruited for an overnight polysomnography (PSG) sleep study. The participants will use the investigational CPAP device and be connected to a PSG during their session. The device performance during the session will be assessed. Outcomes of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires and PSG data.

Enrollment

104 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Diagnosed with OSA by a practicing physician and prescribed PAP therapy (fixed or auto CPAP)
  • Fluent in spoken and written English.

Exclusion criteria

  • Be contraindicated for PAP (fixed or auto CPAP) therapy.
  • Have another significant sleep disorder(s) (e.g. periodic leg movements or insomnia).
  • Have obesity hypoventilation syndrome or congestive heart failure.
  • Require supplemental oxygen with your PAP (fixed or auto CPAP) device.
  • Have any implanted electronic medical devices (e.g. cardiac pacemakers).
  • Be pregnant or think they might be pregnant.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

104 participants in 9 patient groups

Auto CPAP + comfort feature A
Active Comparator group
Description:
Auto CPAP with comfort feature A using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: Auto CPAP + comfort feature A
Auto CPAP with comfort feature B
Active Comparator group
Description:
Auto CPAP with comfort feature B using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: Auto CPAP with comfort feature B
Auto CPAP with no comfort feature
Active Comparator group
Description:
Auto CPAP with no comfort feature using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: Auto CPAP with no comfort feature
Auto CPAP with comfort feature A+B
Active Comparator group
Description:
Auto CPAP with comfort feature A+B using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: Auto CPAP with comfort feature A+B
CPAP with comfort feature A
Active Comparator group
Description:
CPAP with comfort feature A using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: CPAP with comfort feature A
CPAP with comfort feature B
Active Comparator group
Description:
CPAP with comfort feature B using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: CPAP with comfort feature B
CPAP with no comfort feature
Active Comparator group
Description:
CPAP with no comfort feature using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: CPAP with no comfort feature
CPAP with comfort feature A + B
Active Comparator group
Description:
CPAP with comfort feature A + B using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: CPAP with comfort feature A + B
CPAP at Sub therapeutic level
Active Comparator group
Description:
CPAP at Sub therapeutic level using Fisher \& Paykel Healthcare CPAP Device
Treatment:
Device: CPAP at Sub therapeutic level

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems